filter retardation assay using a bio-dot sf microfiltration apparatus (BioDot Inc)
90
Structured Review
BioDot Inc
filter retardation assay using a bio-dot sf microfiltration apparatus
Filter Retardation Assay Using A Bio Dot Sf Microfiltration Apparatus, supplied by BioDot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filter+retardation+assay+using+a+bio-dot+sf+microfiltration+apparatus/filter+retardation+assay+using+a+bio+dot+sf+microfiltration+apparatus/pmc10130388-26-154-154
Average 90 stars, based on 1 article reviews
Filter Retardation Assay Using A Bio Dot Sf Microfiltration Apparatus, supplied by BioDot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filter+retardation+assay+using+a+bio-dot+sf+microfiltration+apparatus/filter+retardation+assay+using+a+bio+dot+sf+microfiltration+apparatus/pmc10130388-26-154-154
Average 90 stars, based on 1 article reviews
filter retardation assay using a bio-dot sf microfiltration apparatus - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders"
Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders
Journal: Frontiers in Molecular Neuroscience
doi: 10.3389/fnmol.2023.1168948
Figure Legend Snippet: In vitro autophagy methods in amyotrophic lateral sclerosis research.
Techniques Used: In Vitro, Expressing, Mutagenesis, Biomarker Discovery, Western Blot, Confocal Microscopy, Construct, Immunofluorescence, Ubiquitin Proteomics, Fluorescence, Modification, Immunoprecipitation, Derivative Assay, Activity Assay, Dot Blot
Related Articles
Expressing:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Derivative Assay:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Activity Assay:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Quantitative RT-PCR:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Western Blot:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Immunofluorescence:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Dot Blot:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a In Vitro:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Mutagenesis:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Biomarker Discovery:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Confocal Microscopy:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Construct:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Ubiquitin Proteomics:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Fluorescence:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Modification:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a Immunoprecipitation:Article Title: In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders Article Snippet: CMA , Substrate degradation , Hsc70 expression and TDP-43 , Primary lymphomonocytes of sporadic ALS patients, lymphoblastoid cell lines derived from sporadic ALS patients, and SH-SY5Y cells , A : Monitoring the expression of TDP-43 and Hsc70 activity in an ALS model consisting of cells engineered to silence Hsc70 to assess CMA-mediated degradation of TDP-43. D : Peripheral blood mononuclear cells from sporadic ALS patients were used to obtain immortalized lymphoblastoid cells. The expression of Hsc70, LAMP2A, Bag1, Bag3, and LPD-43 was measured in both cell lines to assess CMA and LPD-43 accumulation. The expression of Hsc70 was downregulated in SH-SY5Y cells to assess the participation of Hsc70 in TDP-43 degradation. R : (1) Gene and (2) protein expression assessed by qRT-PCR and Western blot, respectively, targeting Hsc70, LAMP2A, and co-chaperones Bag1 and Bag3. Substrate degradation was evaluated by immunofluorescence analysis targeting TDP-43. (3) Identification of insoluble TDP-43 by filter retardation assay using a |